AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Medicalxpress

Published November 11, 2026

Psychedelic aftereffects may offer a window into psychotic symptoms - Medical Xpress

Read the full story at Medicalxpress

But he had taken psychedelics in the past, and he was worried enough to contact Max Greenwald, an M.D.-Ph.D. student at Yale School of Medicine, with.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics